Cargando…

Point of use production of liposomal solubilised products

With the progression towards personalised and age-appropriate medicines, the production of drug loaded liposomes at the point of care would be highly desirable. In particular, liposomal solubilisation agents that can be produced rapidly and easily would provide a new option in personalised medicines...

Descripción completa

Detalles Bibliográficos
Autores principales: Khadke, Swapnil, Stone, Peter, Rozhin, Aleksey, Kroonen, Jerome, Perrie, Yvonne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier/North-Holland Biomedical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821685/
https://www.ncbi.nlm.nih.gov/pubmed/29225099
http://dx.doi.org/10.1016/j.ijpharm.2017.12.012
_version_ 1783301535009079296
author Khadke, Swapnil
Stone, Peter
Rozhin, Aleksey
Kroonen, Jerome
Perrie, Yvonne
author_facet Khadke, Swapnil
Stone, Peter
Rozhin, Aleksey
Kroonen, Jerome
Perrie, Yvonne
author_sort Khadke, Swapnil
collection PubMed
description With the progression towards personalised and age-appropriate medicines, the production of drug loaded liposomes at the point of care would be highly desirable. In particular, liposomal solubilisation agents that can be produced rapidly and easily would provide a new option in personalised medicines. Such a process could also be used as a rapid tool for the formulation and pre-clinical screening of low soluble drugs. Within this paper, we outline a novel easy-to-use production method for point of use production of liposome solubilised drugs. Our results demonstrate that pre-formed multilamellar liposomes, stored in a fresh or frozen format, can be bilayer loaded with low solubility drugs using a simple bath sonication process. Sonication is undertaken in a sealed vial allowing the contents to remain sterile. Liposomes around 100 nm were prepared and these liposomes were able to increase the amount of drug dissolved by up to 10 fold. These liposomal solubilisation agents were stable in terms of size and drug solubilisation for up to 8 days when stored in the fridge making them an easy to use and robust small-scale tool for drug solubilisation.
format Online
Article
Text
id pubmed-5821685
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier/North-Holland Biomedical Press
record_format MEDLINE/PubMed
spelling pubmed-58216852018-02-26 Point of use production of liposomal solubilised products Khadke, Swapnil Stone, Peter Rozhin, Aleksey Kroonen, Jerome Perrie, Yvonne Int J Pharm Article With the progression towards personalised and age-appropriate medicines, the production of drug loaded liposomes at the point of care would be highly desirable. In particular, liposomal solubilisation agents that can be produced rapidly and easily would provide a new option in personalised medicines. Such a process could also be used as a rapid tool for the formulation and pre-clinical screening of low soluble drugs. Within this paper, we outline a novel easy-to-use production method for point of use production of liposome solubilised drugs. Our results demonstrate that pre-formed multilamellar liposomes, stored in a fresh or frozen format, can be bilayer loaded with low solubility drugs using a simple bath sonication process. Sonication is undertaken in a sealed vial allowing the contents to remain sterile. Liposomes around 100 nm were prepared and these liposomes were able to increase the amount of drug dissolved by up to 10 fold. These liposomal solubilisation agents were stable in terms of size and drug solubilisation for up to 8 days when stored in the fridge making them an easy to use and robust small-scale tool for drug solubilisation. Elsevier/North-Holland Biomedical Press 2018-02-15 /pmc/articles/PMC5821685/ /pubmed/29225099 http://dx.doi.org/10.1016/j.ijpharm.2017.12.012 Text en © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Khadke, Swapnil
Stone, Peter
Rozhin, Aleksey
Kroonen, Jerome
Perrie, Yvonne
Point of use production of liposomal solubilised products
title Point of use production of liposomal solubilised products
title_full Point of use production of liposomal solubilised products
title_fullStr Point of use production of liposomal solubilised products
title_full_unstemmed Point of use production of liposomal solubilised products
title_short Point of use production of liposomal solubilised products
title_sort point of use production of liposomal solubilised products
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821685/
https://www.ncbi.nlm.nih.gov/pubmed/29225099
http://dx.doi.org/10.1016/j.ijpharm.2017.12.012
work_keys_str_mv AT khadkeswapnil pointofuseproductionofliposomalsolubilisedproducts
AT stonepeter pointofuseproductionofliposomalsolubilisedproducts
AT rozhinaleksey pointofuseproductionofliposomalsolubilisedproducts
AT kroonenjerome pointofuseproductionofliposomalsolubilisedproducts
AT perrieyvonne pointofuseproductionofliposomalsolubilisedproducts